share_log

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Lowers Price Target to $13

Benzinga ·  Aug 15, 2023 07:15

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and lowers the price target from $14 to $13.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment